Covetrus, Inc.
CVET · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/29/2018 | |
|---|---|---|---|---|
| Revenue | $4,575 | $4,339 | $3,976 | $3,778 |
| % Growth | 5.4% | 9.1% | 5.2% | – |
| Cost of Goods Sold | $3,717 | $3,541 | $3,227 | $3,094 |
| Gross Profit | $858 | $798 | $749 | $684 |
| % Margin | 18.8% | 18.4% | 18.8% | 18.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $867 | $808 | $538 |
| SG&A Expenses | $881 | $867 | $808 | $538 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $881 | $867 | $808 | $538 |
| Operating Income | -$22 | -$69 | -$997 | $137 |
| % Margin | -0.5% | -1.6% | -25.1% | 3.6% |
| Other Income/Exp. Net | -$32 | $43 | -$32 | $6 |
| Pre-Tax Income | -$54 | -$26 | -$1,029 | $143 |
| Tax Expense | $32 | -$7 | -$7 | $37 |
| Net Income | -$86 | -$19 | -$1,019 | $101 |
| % Margin | -1.9% | -0.4% | -25.6% | 2.7% |
| EPS | -0.63 | -0.16 | -9.52 | 0.91 |
| % Growth | -293.7% | 98.3% | -1,146.2% | – |
| EPS Diluted | -0.63 | -0.16 | -9.52 | 0.91 |
| Weighted Avg Shares Out | 137 | 118 | 107 | 111 |
| Weighted Avg Shares Out Dil | 137 | 118 | 107 | 111 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $7 | $0 |
| Interest Expense | $32 | $47 | $56 | $0 |
| Depreciation & Amortization | $200 | $190 | $176 | $64 |
| EBITDA | $179 | $213 | -$794 | $202 |
| % Margin | 3.9% | 4.9% | -20% | 5.3% |